Literature DB >> 22577758

Hypothalamic obesity in children.

A Bereket1, W Kiess, R H Lustig, H L Muller, A P Goldstone, R Weiss, Y Yavuz, Z Hochberg.   

Abstract

Hypothalamic obesity is an intractable form of obesity syndrome that was initially described in patients with hypothalamic tumours and surgical damage. However, this definition is now expanded to include obesity developing after a variety of insults, including intracranial infections, infiltrations, trauma, vascular problems and hydrocephalus, in addition to acquired or congenital functional defects in central energy homeostasis in children with the so-called common obesity. The pathogenetic mechanisms underlying hypothalamic obesity are complex and multifactorial. Weight gain results from damage to the ventromedial hypothalamus, which leads, variously, to hyperphagia, a low-resting metabolic rate; autonomic imbalance; growth hormone-, gonadotropins and thyroid-stimulating hormone deficiency; hypomobility; and insomnia. Hypothalamic obesity did not receive enough attention, as evidenced by rarity of studies in this group of patients. A satellite symposium was held during the European Congress of Obesity in May 2011, in Istanbul, Turkey, to discuss recent developments and concepts regarding pathophysiology and management of hypothalamic obesity in children. An international group of leading researchers presented certain aspects of the problem. This paper summarizes the highlights of this symposium. Understanding the central role of the hypothalamus in the regulation of feeding and energy metabolism will help us gain insights into the pathogenesis and management of common obesity.
© 2012 The Authors. obesity reviews © 2012 International Association for the Study of Obesity.

Entities:  

Mesh:

Year:  2012        PMID: 22577758     DOI: 10.1111/j.1467-789X.2012.01004.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  29 in total

1.  Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes.

Authors:  Anthe S Sterkenburg; Anika Hoffmann; Ursel Gebhardt; Monika Warmuth-Metz; Anna M M Daubenbüchel; Hermann L Müller
Journal:  Neuro Oncol       Date:  2015-04-02       Impact factor: 12.300

2.  Paediatrics: surgical strategy and quality of life in craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2013-06-25       Impact factor: 43.330

3.  Oxytocin in survivors of childhood-onset craniopharyngioma.

Authors:  Anna M M Daubenbüchel; Anika Hoffmann; Maria Eveslage; Jale Özyurt; Kristin Lohle; Julia Reichel; Christiane M Thiel; Henri Martens; Vincent Geenen; Hermann L Müller
Journal:  Endocrine       Date:  2016-09-01       Impact factor: 3.633

Review 4.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

5.  Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series.

Authors:  Christian Denzer; Friederike Denzer; Belinda S Lennerz; Heike Vollbach; Robert H Lustig; Martin Wabitsch
Journal:  Obes Facts       Date:  2019-03-07       Impact factor: 3.942

6.  Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.

Authors:  Kerstin Heinks; Svenja Boekhoff; Anika Hoffmann; Monika Warmuth-Metz; Maria Eveslage; Junxiang Peng; Gabriele Calaminus; Hermann L Müller
Journal:  Endocrine       Date:  2017-12-11       Impact factor: 3.633

7.  The Postopera tive Quality of Life in Children and Adolescents with Craniopharyngioma.

Authors:  Maria Eveslage; Gabriele Calaminus; Monika Warmuth-Metz; Rolf-Dieter Kortmann; Fabian Pohl; Beate Timmermann; Martin Ulrich Schuhmann; Jörg Flitsch; Andreas Faldum; Hermann Lothar Müller
Journal:  Dtsch Arztebl Int       Date:  2019-05-03       Impact factor: 5.594

Review 8.  The Effect of Chronic Exercise Training on Leptin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Michael V Fedewa; Elizabeth D Hathaway; Christie L Ward-Ritacco; Tyler D Williams; Ward C Dobbs
Journal:  Sports Med       Date:  2018-06       Impact factor: 11.136

9.  Low concordance between surgical and radiological assessment of degree of resection and treatment-related hypothalamic damage: results of KRANIOPHARYNGEOM 2007.

Authors:  Hermann L Müller; Julia Reichel; Svenja Boekhoff; Monika Warmuth-Metz; Maria Eveslage; Junxiang Peng; Jörg Flitsch
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

Review 10.  Screening for hormonal, monogenic, and syndromic disorders in obese infants and children.

Authors:  Kelly Mason; Laura Page; Pinar Gumus Balikcioglu
Journal:  Pediatr Ann       Date:  2014-09       Impact factor: 1.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.